THERAPEUTICSMD INC's ticker is TXMD and the CUSIP is 88338N107. A total of 124 filers reported holding THERAPEUTICSMD INC in Q4 2015. The put-call ratio across all filers is 0.35 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2020 | $6,989,000 | -69.5% | 6,594,202 | -30.5% | 0.01% | -58.3% |
Q4 2019 | $22,950,000 | -38.3% | 9,483,556 | -7.4% | 0.01% | -40.0% |
Q3 2019 | $37,178,000 | +40.0% | 10,241,783 | +0.3% | 0.02% | +42.9% |
Q2 2019 | $26,560,000 | -48.3% | 10,215,408 | -3.2% | 0.01% | -50.0% |
Q1 2019 | $51,398,000 | +27.9% | 10,553,807 | +0.1% | 0.03% | +16.7% |
Q4 2018 | $40,171,000 | -40.6% | 10,543,588 | +2.3% | 0.02% | -29.4% |
Q3 2018 | $67,617,000 | +2.8% | 10,307,615 | -2.2% | 0.03% | 0.0% |
Q2 2018 | $65,780,000 | +27.9% | 10,541,642 | -0.2% | 0.03% | +30.8% |
Q1 2018 | $51,431,000 | -22.5% | 10,560,724 | -3.9% | 0.03% | -18.8% |
Q4 2017 | $66,394,000 | +20.9% | 10,992,409 | +5.9% | 0.03% | +18.5% |
Q3 2017 | $54,907,000 | +0.9% | 10,379,444 | +0.5% | 0.03% | 0.0% |
Q2 2017 | $54,413,000 | -27.3% | 10,325,062 | -0.7% | 0.03% | -28.9% |
Q1 2017 | $74,883,000 | +15.3% | 10,400,418 | -7.6% | 0.04% | +11.8% |
Q4 2016 | $64,949,000 | -7.2% | 11,256,377 | +9.5% | 0.03% | -8.1% |
Q3 2016 | $69,974,000 | -17.5% | 10,275,146 | +3.0% | 0.04% | -19.6% |
Q2 2016 | $84,773,000 | +51.7% | 9,973,276 | +14.2% | 0.05% | +53.3% |
Q1 2016 | $55,870,000 | -34.4% | 8,729,595 | +6.3% | 0.03% | -30.2% |
Q4 2015 | $85,135,000 | +111.7% | 8,209,713 | +19.6% | 0.04% | +115.0% |
Q3 2015 | $40,216,000 | -24.9% | 6,862,782 | +0.7% | 0.02% | -16.7% |
Q2 2015 | $53,553,000 | +33.2% | 6,813,382 | +2.5% | 0.02% | +33.3% |
Q1 2015 | $40,203,000 | +113.0% | 6,644,982 | +56.6% | 0.02% | +100.0% |
Q4 2014 | $18,877,000 | +15.9% | 4,241,982 | +20.8% | 0.01% | +28.6% |
Q3 2014 | $16,292,000 | +1.2% | 3,511,182 | -3.6% | 0.01% | 0.0% |
Q2 2014 | $16,099,000 | -30.0% | 3,642,382 | 0.0% | 0.01% | -36.4% |
Q1 2014 | $22,983,000 | +23.1% | 3,642,382 | +1.6% | 0.01% | +22.2% |
Q4 2013 | $18,674,000 | +83.8% | 3,584,282 | +3.4% | 0.01% | +80.0% |
Q3 2013 | $10,160,000 | +25.5% | 3,467,700 | +29.8% | 0.01% | 0.0% |
Q2 2013 | $8,096,000 | – | 2,672,000 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|